ATE362981T1 - Verbindungen zur hydrolyse von ribonukleinsäuren (rns) - Google Patents

Verbindungen zur hydrolyse von ribonukleinsäuren (rns)

Info

Publication number
ATE362981T1
ATE362981T1 AT04075764T AT04075764T ATE362981T1 AT E362981 T1 ATE362981 T1 AT E362981T1 AT 04075764 T AT04075764 T AT 04075764T AT 04075764 T AT04075764 T AT 04075764T AT E362981 T1 ATE362981 T1 AT E362981T1
Authority
AT
Austria
Prior art keywords
compounds
rns
hydrolysis
ribonucleic acids
relates
Prior art date
Application number
AT04075764T
Other languages
English (en)
Inventor
Brigitte Wanner
Gerard Platenburg
Original Assignee
Prosensa Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosensa Bv filed Critical Prosensa Bv
Application granted granted Critical
Publication of ATE362981T1 publication Critical patent/ATE362981T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3181—Peptide nucleic acid, PNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3511—Conjugate intercalating or cleaving agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT04075764T 2004-03-09 2004-03-09 Verbindungen zur hydrolyse von ribonukleinsäuren (rns) ATE362981T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04075764A EP1574572B1 (de) 2004-03-09 2004-03-09 Verbindungen zur Hydrolyse von Ribonukleinsäuren (RNS)

Publications (1)

Publication Number Publication Date
ATE362981T1 true ATE362981T1 (de) 2007-06-15

Family

ID=34814336

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04075764T ATE362981T1 (de) 2004-03-09 2004-03-09 Verbindungen zur hydrolyse von ribonukleinsäuren (rns)

Country Status (12)

Country Link
US (1) US20090233981A1 (de)
EP (1) EP1574572B1 (de)
JP (1) JP2007528224A (de)
CN (1) CN100537763C (de)
AT (1) ATE362981T1 (de)
AU (1) AU2005219815B2 (de)
CA (1) CA2559114A1 (de)
DE (1) DE602004006599T2 (de)
DK (1) DK1574572T3 (de)
ES (1) ES2287634T3 (de)
PL (1) PL1574572T3 (de)
WO (1) WO2005085442A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2308514B1 (de) 2007-03-23 2013-06-05 to-BBB Holding B.V. Konjugate zum Arzneimitteltransport über die Blut-Hirn-Schranke
JP5429039B2 (ja) * 2010-05-17 2014-02-26 株式会社島津製作所 酸加水分解によるｒｎａの分解方法及びそれを用いたｒｎａの配列解析方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07255483A (ja) * 1994-03-22 1995-10-09 Makoto Komiyama リボ核酸を切断する方法
JP3658697B2 (ja) * 1997-01-14 2005-06-08 独立行政法人科学技術振興機構 人工リボヌクレアーゼ及びその製造法

Also Published As

Publication number Publication date
CN100537763C (zh) 2009-09-09
CN1946845A (zh) 2007-04-11
WO2005085442A2 (en) 2005-09-15
DE602004006599D1 (de) 2007-07-05
WO2005085442A3 (en) 2006-01-05
JP2007528224A (ja) 2007-10-11
EP1574572A1 (de) 2005-09-14
EP1574572B1 (de) 2007-05-23
ES2287634T3 (es) 2007-12-16
PL1574572T3 (pl) 2007-10-31
DE602004006599T2 (de) 2008-01-31
AU2005219815A1 (en) 2005-09-15
AU2005219815B2 (en) 2009-08-20
CA2559114A1 (en) 2005-09-15
US20090233981A1 (en) 2009-09-17
DK1574572T3 (da) 2007-09-24

Similar Documents

Publication Publication Date Title
ATE453716T1 (de) Verfahren zur modulation der genexpression durch änderung des cpg gehalts
DE60223299D1 (de) Verfahren zur Sequenzierung von Nukleinsäuren
DE602005001156D1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
DE602005008146D1 (de) Methode für die Quantifizierung der Ausgangs-Konzentration von Nukleinsäuren ausgehend von real-time Amplifikationsdaten
DE602005027700D1 (de) Verfahren zur nukleinsäureimmobilisierung
WO2005065321A3 (en) Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
NO20072722L (no) Preparater og fremgangsmate for a rense nukleinsyrer fra stabiliseringsreagenser
WO2007062160A8 (en) Methods and compositions for sequencing a nucleic acid
DE602006012052D1 (de) Verfahren zur sequenzierung einer polynukleotidmatrize
WO2007057167A3 (en) A method for enhancing enzymatic dna polymerase reactions
DE60223704D1 (de) Vorrichtung zur extraktion von nukleinsäuren
DE602005009693D1 (de) 2"-nitrobenzyl-modifizierte ribonukleotide
DE602007011237D1 (de) Amplifikation von dna-fragmenten
ATA11042002A (de) Verfahren zur simulation des fahrverhaltens von fahrzeugen
DE602006001916D1 (de) System und Verfahren zur Ausgabe von Fahrempfehlungen
DE602004023631D1 (de) Verfahren zur einführung einer nukleinsäure
ATE435296T1 (de) Verfahren zur verbesserung der genexpression in pflanzen
DE602004026253D1 (de) Verfahren zur Herstellung von Stahlbrammen mit ultra-geringem Kohlenstoffgehalt
DE602004022429D1 (de) Verfahren zur hydrocyanierung von ungesättigten carbonsäure-derivaten
ATE362981T1 (de) Verbindungen zur hydrolyse von ribonukleinsäuren (rns)
MX2012005508A (es) Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas.
DE502004001216D1 (de) Verfahren zur aufreinigung von blausäure
DE50204680D1 (de) Verfahren zur detektion von nukleinsäuremolekülen
DE602007009393D1 (de) Verfahren zur verstärkung durch räumlich-zeitliche frequenzumsetzung und einrichtung zum ausführen des verfahrens
DE60331072D1 (de) Verfahren zur unspezifischen amplifizierung nukleinsäuren mit niedriger komplexität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties